Senile Scleral Plaque

Senile scleral plaque is an age-related change in the white coat of the eye, which doctors call the sclera. It looks like a flat, well-defined, slate-gray or gray-white patch on the eyeball. It usually sits just in front of where the horizontal eye muscles attach to the sclera. These muscles are the medial and lateral rectus muscles that move the eye side to side. The plaque can be on one eye or both eyes. It is often found by chance during a routine eye exam because most people do not feel anything from it. Over time, the central part of the plaque can gather calcium. When that happens, the patch can show up as a small, oval calcification on a CT scan. Doctors view this as a benign, slow, wear-and-tear change of the aging sclera, not a cancer and not an infection. RadiopaediaWebEye

Senile scleral plaque is most common in older adults, especially after age 70. Studies show that these plaques are seen more with increasing age, and a portion of them develop calcium in the middle. Some reports describe higher prevalence in women. These numbers vary by study, but the pattern is the same: the older the patient group, the more often plaques are found. EyeWiki

Senile scleral plaque is a common, age-related change in the sclera, the tough white coat of the eye. Over many years the sclera in certain spots becomes a little thinner, stiffer, and more translucent because the collagen in that area slowly degenerates and hardens (hyalinizes) and can pick up calcium. These spots often look like flat, oval, slate-gray or bluish-gray patches on the white part of the eye. They sit just in front of the tendons of the horizontal eye muscles, so doctors most often see them toward the 3 o’clock and 9 o’clock positions (nasal and temporal), near but not at the colored part of the eye.

Doctors think the plaque forms because the sclera in that specific area is under long-term stress and slowly degenerates. The exact cause is not one single factor. It seems to be a mix of long-standing mechanical stress from the eye muscles pulling on that spot, drying or dehydration of the tissue, and many years of sun exposure. All of these can lead to local tissue aging, hyaline change, and then dystrophic calcification in the center of the plaque. In other words, the tissue degenerates first and then calcium settles into the old, worn-out spot. RadiopaediaEnto Key

Most plaques stay quiet and cause no problem. Rarely, a calcified plaque can break through and be expelled, and that can leave a thin area of sclera, a condition called scleromalacia. This complication is unusual, but it has been described in case reports. PubMedcanadianjournalofophthalmology.ca

Types

1. By stage (what the tissue looks like):
   • Early, non-calcified plaque: the patch looks gray and flat at the slit lamp, with no hard calcium seen on imaging. It is basically a well-defined area of hyaline (glassy) degeneration.
   • Late, calcified plaque: the center has calcium. On CT it may show up as a small, oval calcification. On OCT it may look like a bright, reflective block with a shadow beneath it. Both types are benign, and both tend to stay stable or progress very slowly. RadiopaediaWiley Online Library

2. By location:
   • Nasal side (near the medial rectus insertion).
   • Temporal side (near the lateral rectus insertion).
   These are the classic sites because the horizontal rectus muscles insert here. Radiopaedia

3. By laterality:
   • Unilateral (one eye) or bilateral (both eyes). Many patients have plaques in both eyes because both eyes age the same way.

These “types” are not separate diseases. They are simple labels doctors use to describe what they see.

Causes

The true cause is age-related degeneration of scleral tissue right in front of the horizontal muscle insertions. Below are 20 simple, patient-friendly “causes or contributors.” Think of them as gentle pushes that act together over decades. Some are well supported, and some are reasonable, expert-level possibilities used to explain why plaques prefer that exact spot.

1. Advanced age: the strongest factor. The tissue has had more years to undergo slow wear and tear. The older the person, the more common the plaque. EyeWiki

2. Lifelong sunlight exposure: many years of UV light can age the surface tissues of the eye. The interpalpebral region gets the most light when the eyes are open, which adds stress to the sclera. Radiopaedia

3. Mechanical stress from the horizontal rectus muscles: the constant pulling during eye movements concentrates stress near their insertions, which may promote local degeneration and later calcification. RadiopaediaEnto Key

4. Local dehydration of the sclera: mild drying of exposed tissue over many years can push the sclera toward hyaline change, which then calcifies. Radiopaedia

5. Age-related change in scleral collagen: with age, collagen fibers can become thicker and less uniform, and this can make the tissue more prone to plaque formation. Ento Key

6. Ischemia from small-vessel atherosclerosis: reduced micro-circulation around the anterior ciliary arteries has been suggested as one more push toward tissue degeneration. Ento Key

7. Female sex (population signal): some studies note higher prevalence in women, likely reflecting differences in lifespan or tissue biology rather than a direct “cause.” EyeWiki

8. Cumulative environmental exposure (wind, dust, dryness): years of exposure can irritate the ocular surface micro-environment and add to tissue wear.

9. Thin ocular surface tissues with aging: the conjunctiva and episclera can become more fragile with age, making the underlying sclera more vulnerable to focal change.

10. Lower blink rate in prolonged visual tasks: long hours with the eyes open can dry the interpalpebral area and add to local stress over time.

11. Systemic dehydration episodes over a lifetime: repeated episodes may not cause plaques by themselves but can contribute to scleral dryness and micro-injury.

12. Nutritional imbalances over decades: not a direct cause, but poor long-term nutrition can reduce tissue repair capacity, letting wear-and-tear effects add up.

13. Chronic ocular surface disease: long-standing dryness, blepharitis, or meibomian gland dysfunction may slightly raise local stress and dryness on the exposed sclera.

14. Past minor conjunctival inflammation: small inflammatory insults that heal can still leave tiny changes that make later hyaline degeneration more likely.

15. Naturally high exposure to reflected light (snow or water): people living or working where light bounces into the eyes may collect more UV exposure over a lifetime.

16. Occupational outdoor work: more years in the sun can increase local actinic effects on the ocular surface.

17. Lifelong eye movement patterns: people who regularly use wide side gazes (driving, scanning) may place tiny extra loads on the horizontal muscle insertions across decades.

18. Scleral biomechanical variability: everyone’s sclera is slightly different in thickness and stiffness, so some people are naturally more prone to focal aging changes.

19. Dystrophic calcification tendency in aged tissue: when any tissue ages and hyalinizes, it can collect calcium even when blood calcium levels are perfectly normal. This general rule applies to scleral plaques. Radiopaedia

20. Rare links to broader vascular calcification patterns: a study noted a mild association with calcification in other head vessels on imaging, but this is not a proven driver, only an observed correlation in some radiology series. Clinical Radiology Online

Symptoms

1. Most people feel nothing at all. This is the most important point. The plaque is usually an incidental finding with no pain and no vision change. Lippincott Journals

2. A visible gray spot noticed in the mirror or by a family member. The spot is flat, well-defined, and looks different from the surrounding white sclera.

3. A sense of “something looks different” on the white of the eye. People may describe a cosmetic concern rather than discomfort.

4. Mild awareness when looking to the side. This is uncommon and usually not true “discomfort,” just awareness of the spot’s presence.

5. Dryness symptoms from the ocular surface in the same region. The plaque itself is not dry, but the interpalpebral area is naturally more exposed to air and can feel dry.

6. Occasional mild irritation if the overlying conjunctiva is a little inflamed. This is from the surface tissue, not the plaque itself.

7. No light sensitivity from the plaque itself. If light sensitivity exists, it is usually from another eye surface problem.

8. No floaters from the plaque itself. Floaters come from inside the eye and are unrelated.

9. No halos or glare from the plaque itself. These symptoms come from the cornea or lens, not the sclera.

10. No double vision from the plaque itself. Double vision would suggest a muscle or nerve issue, not a quiet plaque.

11. Very rare localized tenderness if there is associated surface inflammation. This is not common and should be checked.

12. Very rare ache if there is separate scleritis. Scleritis is a different, painful disease and needs urgent care.

13. Injection-related difficulty (doctor experience): an eye doctor may notice more resistance during a transscleral injection in that area because the plaque is harder. Patients do not feel this difference as a separate symptom, but it matters for procedures. Wiley Online Library

14. Anxiety about the spot. People often worry about cancer. It is important to know this lesion is benign and age related. Radiopaedia

15. Rare softening or thinning after plaque expulsion, called scleromalacia. This is exceptional, but if it happens, the eye can become tender and needs prompt care. PubMedcanadianjournalofophthalmology.ca

Diagnostic Tests

Most patients only need an eye exam. Extra tests are chosen to confirm the diagnosis, document the finding, or rule out other problems. Electrodiagnostic tests are almost never needed and are listed here only for completeness when symptoms do not match a harmless plaque.

A) Physical Exam

1. Visual acuity (distance and near).
   Your vision is measured with an eye chart. A plaque does not affect the clear front window of the eye or the retina, so eye chart results are usually normal for age.

2. External inspection in room light.
   The doctor gently pulls the lids and looks at the white of the eye. A plaque looks like a flat, well-outlined gray patch in front of the horizontal muscle insertion.

3. Slit-lamp biomicroscopy.
   A microscope with a thin beam examines the front of the eye. The doctor sees a sharp-edged, flat, slate-gray area with healthy surrounding tissue. This classic look usually makes the diagnosis on the spot. WebEye

4. Ocular motility testing (versions and ductions).
   You follow a target in all directions. This helps expose the muscle insertion areas and also confirms that the eye muscles move normally, which they do in typical plaques.

5. Intraocular pressure measurement (Goldmann applanation).
   Pressure is checked to complete the front-of-eye exam. The plaque does not raise eye pressure, but this test is part of a thorough check.

B) “Manual” Chairside Tests ( tests done with simple tools at the slit lamp)

6. Eyelid retraction and gaze positioning.
   The doctor asks you to look inward or outward so the muscle insertion area comes into view. This simple step often makes the plaque easy to see.

7. Penlight transillumination.
   A bright light is shined across the surface to see how the area transmits or reflects light. A plaque looks denser and more opaque than normal sclera.

8. Fluorescein dye staining of the surface.
   A yellow dye shows dryness or tiny surface damage. The dye does not stain a plaque itself but can reveal any unrelated surface dryness nearby.

9. Phenylephrine blanching test (if the eye is red).
   A drop of phenylephrine temporarily blanches superficial vessels. This helps separate simple surface redness from deeper inflammation. It does not diagnose the plaque directly, but it helps when a red eye is present for other reasons.

10. Gentle palpation for tenderness.
    The doctor gently presses over the area with a cotton tip to check for pain. A typical plaque is not tender; tenderness suggests another condition.

C) Laboratory and Pathological Tests ( tests, used selectively)

Blood tests are not required to diagnose a plaque. They are used when the doctor wants to rule out other causes of calcification or inflammation.

11. Serum calcium (corrected for albumin).
    This checks for true high calcium. Dystrophic calcification in plaques usually occurs even when blood calcium is normal, but this test helps exclude metabolic causes when the picture is unclear.

12. Serum phosphate and magnesium.
    These minerals partner with calcium. Abnormalities are uncommon in simple plaques but are checked if broader calcium-phosphorus problems are suspected.

13. Parathyroid hormone and vitamin D.
    These control calcium balance. They are measured if there is a question about systemic calcium metabolism.

14. Kidney function (creatinine, BUN, eGFR).
    Kidney disease can affect mineral balance. This is checked if the doctor thinks there may be a systemic mineral issue rather than a simple, local plaque. Radiopaedia

D) Electrodiagnostic Tests ( tests, rarely needed)

15. Visual evoked potential (VEP).
    This measures the electrical signal from the eye to the brain. It is only ordered if there is unexplained vision loss that does not match a harmless plaque.

16. Electroretinography (ERG).
    This checks the retina’s electrical response. It is done only if the doctor suspects a retinal disease. A plaque alone does not change the ERG.

E) Imaging Tests

17. Slit-lamp photography (documentation).
    A photo records the size, shape, and position of the plaque. This is helpful to compare over time.

18. Anterior segment OCT (including enhanced-depth OCT).
    OCT is a light-based scan that shows the layers at the front of the eye. A plaque appears as a bright, dense, superficial block with a shadow below it because the calcium blocks light. OCT helps confirm the lesion is in the sclera and not in the cornea. Wiley Online Library

19. Ultrasound biomicroscopy (UBM) or B-scan ultrasound.
    These ultrasound methods can show a highly reflective spot and help map the thickness and position of the plaque when the view is difficult.

20. CT scan of the orbits (non-contrast).
    CT is very sensitive to calcium. It shows small, oval calcifications along the front of the globe, right where the medial and lateral rectus muscles insert. Plaques are a common incidental finding on CT in older adults. CT is usually not needed if the slit-lamp view is clear; it is reserved for unusual cases or when imaging is done for other reasons. Radiopaedia

Non-pharmacological treatments (therapies & others)

Goal: protect the eye, keep the surface healthy, reduce friction and dryness, and avoid trauma. None of these “dissolve” a plaque; they keep you comfortable and safe.

1. Education and watchful monitoring
   Description: Your eye-care professional explains what the plaque is and tracks it at regular visits.
   Purpose: Reduce worry, catch any rare changes early.
   Mechanism: Early detection and reassurance; avoids unnecessary treatment.

2. Protective eyewear for risky activities
   Description: Use safety glasses for gardening, DIY, sports with flying debris.
   Purpose: Prevent minor trauma to a thinned area.
   Mechanism: Physical barrier blocks impact and particles.

3. Sunglasses with good UV/HEV protection
   Description: Wrap-around sunglasses outdoors.
   Purpose: Reduce long-term light-related tissue stress and surface irritation.
   Mechanism: Filters ultraviolet and harsh visible light, stabilizes tear film by reducing wind/airflow.

4. Wind and dust control
   Description: Use moisture chamber glasses in windy, dry environments.
   Purpose: Lessen evaporation and airborne irritants.
   Mechanism: Creates a humid micro-environment around the eye.

5. Humidify your indoor air
   Description: Room humidifier to ~40–50% humidity.
   Purpose: Reduce dry-air irritation.
   Mechanism: Slows tear evaporation; smoother blinking.

6. Blink training and screen breaks
   Description: Follow the 20-20-20 rule; full intentional blinks.
   Purpose: Improve tear distribution and surface lubrication.
   Mechanism: Frequent complete blinks spread tears evenly and refresh the surface.

7. Warm compresses and gentle lid hygiene
   Description: Warm compress 5–10 minutes daily; then lid wipe with diluted baby shampoo or commercial wipes.
   Purpose: Support meibomian glands so tears are more stable.
   Mechanism: Heat melts thick oils; hygiene reduces debris along lashes.

8. Preservative-free ocular surface care
   Description: When using any drops (even lubricants), choose preservative-free single-use vials whenever possible.
   Purpose: Minimize chemical irritation from preservatives.
   Mechanism: Reduces exposure to benzalkonium chloride (BAK) and similar agents that can irritate the surface.

9. Nighttime eye shield or sleep mask
   Description: Soft mask to prevent rubbing on pillows.
   Purpose: Protects from accidental nocturnal pressure on a thinned area.
   Mechanism: Physical barrier; reduces friction.

10. Allergy avoidance
    Description: Identify and avoid allergens (dust mites, pollen) and use cool compresses when itchy.
    Purpose: Cut down eye rubbing triggered by itch.
    Mechanism: Less histamine-driven itch → less rubbing → less mechanical stress.

11. Quit smoking
    Description: Stop tobacco exposure.
    Purpose: Improve tissue oxygenation and surface health.
    Mechanism: Less oxidative stress and vasoconstriction on ocular tissues.

12. Hydration habits
    Description: Regular water intake through the day.
    Purpose: Support tear production and surface comfort.
    Mechanism: Adequate hydration helps lacrimal gland function and mucosal moisture.

13. Omega-3–rich diet
    Description: Fatty fish (salmon, sardines) 2–3 times weekly, or plant ALA sources (flax, chia, walnuts).
    Purpose: Support meibomian gland function and tear quality.
    Mechanism: Anti-inflammatory lipid profile improves tear film stability.

14. Scleral or PROSE lens for advanced surface protection
    Description: Special large-diameter lenses vault the cornea and bathe it in fluid.
    Purpose: Cushion and protect the ocular surface in people with severe dryness or exposure risk.
    Mechanism: Creates a liquid reservoir that reduces friction; also shields from air currents.

15. Bandage contact lens (short-term, supervised)
    Description: Soft lens fitted by an eye-care professional for temporary protection.
    Purpose: Reduce friction in acute surface irritation.
    Mechanism: Mechanical barrier between lids and ocular surface.

16. Punctal occlusion (plugs)
    Description: Tiny plugs placed in the tear drainage openings (clinic procedure).
    Purpose: Keep natural tears and lubricants on the eye longer.
    Mechanism: Slows tear outflow; improves moisture time.

17. Treat eyelid malposition or lagophthalmos
    Description: If lids do not meet fully, address with taping, moisture shields, or surgical correction if needed.
    Purpose: Prevent exposure-related dryness over the plaque zone.
    Mechanism: Better lid closure = better protection and lubrication.

18. Optimize systemic health
    Description: Control blood pressure, diabetes, and cardiovascular health; regular exercise as appropriate.
    Purpose: Support microcirculation and healing capacity of ocular tissues.
    Mechanism: Healthier vessels and collagen metabolism may improve overall tissue resilience.

19. Gentle eye care routine
    Description: Avoid harsh soaps around eyes; do not use expired or shared cosmetics; remove makeup fully.
    Purpose: Reduce irritation and infection risk.
    Mechanism: Keeps ocular surface clean and calm.

20. Regular professional checkups
    Description: Scheduled visits for slit-lamp examination.
    Purpose: Track stability, measure any thinning, and plan protection.
    Mechanism: Early detection → timely protective steps if needed.

---

Drug treatments

Key point: no medicine “erases” a senile scleral plaque. Medicines are used to improve surface comfort, reduce inflammation if present, and protect the area. Always use under the guidance of an eye-care professional.

1. Preservative-free artificial tears (e.g., carboxymethylcellulose 0.5% or sodium hyaluronate 0.1–0.3%)
   Class: Ocular lubricants.
   Dosage/Time: 1–2 drops, 3–6×/day (or as needed); single-use vials preferred.
   Purpose: Moisturize and cushion the ocular surface.
   Mechanism: Adds a protective fluid layer; reduces friction.
   Side effects: Rare; transient blur; allergy to components is uncommon.

2. Lubricating gel/ointment (night use)
   Class: Petrolatum/mineral oil gels or vitamin-A ointments.
   Dosage/Time: 0.5–1 cm ribbon at bedtime.
   Purpose: Overnight protection from exposure and dryness.
   Mechanism: Thick layer reduces evaporation during sleep.
   Side effects: Temporary blur; mild stickiness.

3. Topical cyclosporine A (0.05–0.1%)
   Class: Calcineurin inhibitor (anti-inflammatory for dry eye disease).
   Dosage/Time: 1 drop in each affected eye twice daily; benefits build over weeks.
   Purpose: Improve basal tear production and reduce surface inflammation in concomitant dry eye.
   Mechanism: T-cell modulation in lacrimal functional unit.
   Side effects: Temporary burning; rare allergy.

4. Lifitegrast 5%
   Class: LFA-1 antagonist (anti-inflammatory for dry eye disease).
   Dosage/Time: 1 drop twice daily.
   Purpose: Reduce ocular surface inflammation and symptoms.
   Mechanism: Blocks T-cell adhesion (LFA-1/ICAM-1).
   Side effects: Dysgeusia (odd taste), mild irritation.

5. Short course low-potency steroid (e.g., fluorometholone 0.1% or loteprednol 0.2–0.5%)
   Class: Topical corticosteroid.
   Dosage/Time: Typically q.i.d. for 1–2 weeks, then taper per clinician.
   Purpose: Calm short-term surface inflammation if present.
   Mechanism: Broad cytokine suppression.
   Side effects: Possible rise in eye pressure, cataract risk with prolonged use—must be monitored.

6. Topical vitamin-A ointment (retinyl palmitate)
   Class: Epithelial support.
   Dosage/Time: Thin ribbon at night or as directed.
   Purpose: Support surface epithelium in severe dryness.
   Mechanism: Aids mucin expression and epithelial differentiation.
   Side effects: Mild irritation; avoid excess systemic vitamin A intake.

7. Autologous serum tears (20–50%, compounded, specialist care)
   Class: Biologic tear substitute.
   Dosage/Time: Commonly 4–8×/day under sterile storage.
   Purpose: For severe ocular surface disease to improve comfort over a thinned area.
   Mechanism: Provides growth factors (EGF, TGF-β), vitamins, and fibronectin similar to natural tears.
   Side effects: Infection risk if not handled correctly; requires refrigeration and careful compounding.

8. Platelet-rich plasma (PRP) eye drops (specialist use)
   Class: Autologous biologic.
   Dosage/Time: Often 4–6×/day; protocol varies.
   Purpose: Severe surface disease not controlled by standard therapy.
   Mechanism: Platelet-derived growth factors support epithelial health.
   Side effects: Similar handling risks as serum; not standard everywhere.

9. Oral doxycycline (50 mg once daily)
   Class: Tetracycline-class antibiotic with anti-inflammatory effect.
   Dosage/Time: 50 mg daily for several weeks to months in selected cases of meibomian gland dysfunction.
   Purpose: Improve oil quality and reduce ocular surface inflammation.
   Mechanism: Inhibits matrix metalloproteinases and reduces meibomian gland inflammation.
   Side effects: Photosensitivity, GI upset; avoid if contraindicated.

10. Topical sodium hyaluronate gel formulations (higher viscosity)
    Class: Viscous lubricant.
    Dosage/Time: 3–6×/day or as needed.
    Purpose: Long-lasting lubrication for significant dryness.
    Mechanism: Mucoadhesive hydration; prolongs tear residence time.
    Side effects: Temporary blur after instillation.

Important: Topical NSAIDs are generally avoided for routine surface comfort because of rare corneal toxicity risks. No medicine dissolves a scleral plaque; treatment targets comfort and protection.

---

Dietary molecular supplements

Discuss with your clinician, especially if you have other medical conditions or take blood thinners. Doses here are typical ranges, not personal prescriptions.

1. Omega-3 (EPA/DHA) 1,000–2,000 mg/day combined
   Function: Support tear quality, reduce surface inflammation.
   Mechanism: Anti-inflammatory lipid mediators (resolvins/protectins).

2. Vitamin D3 1,000–2,000 IU/day
   Function: Immune modulation and epithelial support (if deficient).
   Mechanism: Nuclear receptor signaling influences mucosal immunity.

3. Vitamin C 500 mg/day
   Function: Collagen co-factor and antioxidant.
   Mechanism: Ascorbate supports collagen cross-linking and reduces oxidative stress.

4. Zinc 10–20 mg/day (short courses unless deficient)
   Function: Epithelial repair co-factor.
   Mechanism: Enzymatic co-factor in protein synthesis and antioxidant enzymes.

5. Lutein + Zeaxanthin (10 mg + 2 mg/day)
   Function: Ocular surface and retinal antioxidant support.
   Mechanism: Carotenoids quench reactive oxygen species.

6. N-acetylcysteine (NAC) 600 mg once or twice daily
   Function: Mucolytic/antioxidant; may help with mucin layer quality.
   Mechanism: Precursor to glutathione; reduces oxidative stress.

7. Curcumin (Meriva-type or similar) 500–1,000 mg/day
   Function: Systemic anti-inflammatory support.
   Mechanism: NF-κB pathway modulation; antioxidant.

8. Collagen peptides 5–10 g/day
   Function: General connective tissue support.
   Mechanism: Provides amino acids (glycine, proline) used in collagen turnover.

9. Hyaluronic acid oral 120–240 mg/day
   Function: Mucosal hydration support.
   Mechanism: Hygroscopic molecule binds water; limited but growing evidence.

10. Mixed tocopherols (Vitamin E) 100–200 IU/day
    Function: Antioxidant partner with vitamin C.
    Mechanism: Lipid membrane protection from peroxidation.

Supplements do not reverse a plaque. They focus on surface comfort and general tissue health.

---

Regenerative / stem-cell

There are no approved stem-cell drugs that regenerate sclera for senile scleral plaque. The items below are either supportive biologics or investigational. Always discuss risks, sourcing, and regulations with your ophthalmologist.

1. Autologous serum tears (20–50%)
   Dosage: 4–8×/day under specialist care.
   Function: Support severe ocular surface disease.
   Mechanism: Delivers natural growth factors (EGF, TGF-β), vitamins, and fibronectin from your own serum.

2. Platelet-rich plasma (PRP) eye drops
   Dosage: 4–6×/day, protocol dependent.
   Function: Biologic support for epithelium in severe dryness.
   Mechanism: Platelet-released growth factors aid epithelial healing.

3. Amniotic membrane extract drops (where available)
   Dosage: Varies by product/clinic.
   Function: Anti-inflammatory and pro-healing signaling.
   Mechanism: Cytokines and matrix components from amniotic tissue.

4. Mesenchymal stem-cell (MSC)–derived exosomes (experimental)
   Dosage: Investigational only; no standard regimen.
   Function: Proposed paracrine healing signals.
   Mechanism: Exosomal microRNAs/proteins may modulate inflammation and healing; not approved for SSP.

5. Vitamin D3 (systemic immune modulator) 1,000–2,000 IU/day if low
   Function: Broad immune tone support; correct deficiency.
   Mechanism: Vitamin D receptor signaling in immune cells; adjunctive only.

6. N-acetylcysteine 600 mg once or twice daily
   Function: Antioxidant and mucolytic support; sometimes used topically for filamentary keratitis (separate condition).
   Mechanism: Boosts glutathione; reduces oxidative stress; supportive, not regenerative.

Bottom line: For senile scleral plaque, true regenerative or stem-cell drug therapy does not exist in routine care. If you see such claims online, be cautious and discuss with your ophthalmologist.

---

Surgical/Procedural options

These are rarely needed. They are used when the area is very thin, painful, exposed, or at genuine risk of perforation, or if other pathology coexists.

1. Scleral patch graft (donor sclera)
   Procedure: The surgeon places a shaped piece of donor sclera over the thinned area and sutures it in place; conjunctiva is closed over it.
   Why it’s done: To reinforce a dangerously thin sclera and restore the eye’s protective wall.

2. Conjunctival advancement flap
   Procedure: The conjunctiva (the clear pink tissue over the white of the eye) is mobilized and advanced to cover the thin plaque area.
   Why it’s done: Provides biologic coverage, improves comfort, and shields from friction.

3. Amniotic membrane graft (AMT)
   Procedure: Processed amniotic membrane is placed over the area and secured with sutures or fibrin glue; often under a bandage lens.
   Why it’s done: Anti-inflammatory and pro-healing coverage for fragile ocular surface.

4. Tenon’s patch graft
   Procedure: A piece of the patient’s own Tenon’s capsule (a natural tissue layer under conjunctiva) is used as a patch over the thin sclera.
   Why it’s done: Autologous reinforcement when donor tissue is not used.

5. Lamellar scleral reinforcement with tectonic graft
   Procedure: Carefully removes diseased superficial sclera and places a lamellar (partial-thickness) graft to thicken and strengthen the wall.
   Why it’s done: Structural strengthening in selected severe thinning.

The goal of these procedures is protection and reinforcement, not cosmetic whitening. Decisions are individualized after slit-lamp and imaging assessments.

---

Prevention and protection tips

1. Don’t rub your eyes, even when itchy—use cool compresses instead.

2. Wear sunglasses outdoors; consider wrap-around styles.

3. Use safety glasses for any activity with dust, debris, or tools.

4. Keep air moist (humidifier) and avoid direct fans into your face.

5. Follow a gentle lid/tear routine (warm compress + blink breaks).

6. Choose preservative-free eye products when possible.

7. Stay hydrated and maintain a nutrient-dense diet.

8. Quit smoking and avoid secondhand smoke.

9. Manage allergy triggers to avoid rubbing.

10. See your eye-care professional regularly to document stability.

---

When to see a doctor promptly

• New pain, marked redness, or light sensitivity.

• Sudden change in vision (blur, shadows, or distortion).

• A new raised spot, ulcer, or visible “gap” in the white of the eye.

• Recent eye injury or a strong poke to the area of the plaque.

• Rapid growth or color change of a spot.

• Persistent foreign-body sensation that does not improve with lubrication.

• Any concern after eye surgery or invasive eye procedures.

---

What to eat and what to avoid

What to eat:

1. Fatty fish (salmon, sardines, mackerel) 2–3×/week for omega-3s.

2. Citrus and berries for vitamin C and antioxidants.

3. Leafy greens (spinach, kale) for carotenoids and micronutrients.

4. Nuts and seeds (walnuts, flax, chia) for healthy fats and minerals.

5. Eggs and colorful vegetables (peppers, carrots) for vitamin A precursors.

What to avoid or limit:

1. Smoking and vaping—they dry and irritate the surface.
2. Excess alcohol, which dehydrates and worsens sleep quality.
3. Highly processed snacks high in salt/sugar that can promote inflammation or dehydration.
4. Very high-dose vitamin A supplements without guidance—risk of toxicity.
5. Overuse of caffeinated energy drinks—can dehydrate and worsen blepharospasm/wink frequency.

---

FAQs

1) Can senile scleral plaque make me go blind?
No. It is a surface wall change, not a retina or optic nerve disease. Vision is generally normal unless something else is going on.

2) Is it the same as scleritis?
No. Scleritis is painful and inflamed; scleral plaque is non-inflammatory and painless in most cases.

3) Will the gray patch spread across my eye?
It usually stays localized and stable for years. Doctors track its size at checkups.

4) Can drops remove the plaque?
No. Drops cannot dissolve the plaque. Drops help comfort, lubrication, and surface health.

5) Do I need surgery?
Almost never. Surgery is reserved for rare severe thinning, exposure, or risk of perforation. Most people only need protection and monitoring.

6) Is it caused by too much calcium in my diet?
No. The calcium is a local deposition in aged tissue, not from high dietary calcium. Do not restrict calcium unless your doctor advises for other reasons.

7) Is it cancer? Can it become cancer?
No. This is a benign degenerative change, not a tumor, and it does not “turn into” cancer.

8) Can rubbing my eyes make it worse?
Rubbing increases mechanical stress on a thinner area and can irritate the surface. Avoid rubbing; use cool compresses and allergy control instead.

9) Will blue-light filters or computer glasses help?
They may reduce strain and squinting, which indirectly helps comfort, but they do not change the plaque itself.

10) Can contact lenses be worn?
Possibly, with professional fitting. Some people benefit from scleral lenses for surface protection. Your optometrist or ophthalmologist will advise.

11) Is laser treatment an option?
No standard laser reverses a scleral plaque. This is different from band keratopathy on the cornea, where EDTA chelation is sometimes used; that is not for scleral plaque.

12) Does sunlight cause it?
Sun exposure over a lifetime may contribute to surface aging, but senile scleral plaque is mainly an age-related collagen change. UV protection is still wise.

13) Will diet cure it?
Diet won’t erase a plaque. A healthy diet can support tear quality and healing capacity, improving comfort.

14) How often should I be checked?
Your doctor will set a schedule—often yearly for stable cases, sooner if there are symptoms or other eye conditions.

15) What’s the single most important thing I can do?
Protect your eyes (no rubbing, use sunglasses and safety glasses), keep the surface well lubricated, and attend regular checkups.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 24, 2025.